Ligand sees opportunities in CyDex acquisition; deal could help company diversify, boost cash flow.
San Diego Business Journal › February 07, 2011
Linked as:
Extract
Ligand sees opportunities in CyDex acquisition; deal could help company diversify, boost cash flow.
Ligand Pharmaceuticals Inc. of La Jolla has bought CyDex Pharmaceuticals Inc. in a deal that Ligand officials predict will more than double revenue while broadening its potential for ...
See the full content of this document
Sponsored links
